Skip to Main Content

Paper Details

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.
Neuro Oncol
110
2014
BVZ, Brain Tumor, CPT-11, VEGF, VEGF receptor 2, bevacizumab, carbonic anhydrase 9, children, epistaxis, fatigue, hypertension, hypoxia-inducible factor 2, irinotecan, low-grade glioma, low-grade gliomas, patients, proteinuria, recurrent, vascular endothelial growth factor
Author NameAffiliation
Sridharan GururanganDuke University Medical Center
  • 1 - 1

Datasets

Release 1.2